Description
Nitto Denko Avecia Inc. is a recognised leader in the manufacturing and development services of oligonucleotide therapeutics. With facilities located in Milford, MA; Marlboro, MA; and Cincinnati, OH, the company offers comprehensive services for DNA, RNA, and other oligonucleotide-based therapeutics, supporting clients from milligram scale at the pre-clinical stage to over 1000kg post-commercial launch. Nitto Denko Avecia is a proud member of the Nitto Group, further enhancing its capabilities and expertise within the pharmaceutical industry.
Services include:
– Regulatory Services
– Active Pharmaceutical Ingredients (APIs)
– Analytical Services
– Process Development
– Quality Assurance
Nitto Avecia stands out as a trusted supplier to the pharmaceutical industry, committed to quality and innovation in oligonucleotide synthesis and manufacturing. For more information, please visit avecia.com.
Contact Information
Related Listings

CDMO Live Americas . October 20-21, Boston 2026
Experience the future of external manufacturing at CDMO Live, Rotterdam.
19-21st Oct 2026

AI + Digital Maturity in Contract Manufacturing 2026
Exclusive research roundtable on Day Zero of CDMO Live Americas 2026, in partnership with MasterControl










